retatrutide eli lilly press release 2024 2025 date Eli Lilly's retatrutide is still in clinical trials. But gym bros Eli Lilly stock jumps on
Description
Want more on GLP-1 agonists
Alabert et al., 2020)
Nature (1981) 289(5797):5146
You may still have coverage
Theyve been around for more than a decade, he tells Flow Space
Panchapakesan, U
